E9KL23 (E9KL23_HUMAN) Homo sapiens (Human)
Serpin peptidase inhibitor clade A member 1 isoform 1 UniProtKBInterProInteractive Modelling
418 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P01009
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM |
Heteromer P01009; | 1×NAG; 2×NAG; 1×CYS; | ||||
Assess | ||||||
NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN |
Heteromer P00760; P01009; | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX |
Heteromer P00760; P01009; | |||||
Assess | ||||||
Cleaved alpha-1-antitrypsin polymer |
Heteromer P01009; | |||||
Assess | ||||||
Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin in complex with its antigen |
Heteromer P01009; | 2×NA; 1×SO4; | ||||
Assess | ||||||
Fab fragment of a native monomer-selective antibody in complex with alpha-1-antitrypsin |
Heteromer P01009; | |||||
Assess | ||||||
Active site distortion is sufficient for proteinase inhibit second crystal structure of covalent se… |
Heteromer P00772; P01009; | |||||
Assess | ||||||
Crystal structure of an alpha-1-antitrypsin trimer | homo-3-mer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER | homo-2-mer | |||||
Assess | ||||||
THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM | homo-2-mer | 1×NAG; 2×NAG; 1×CYS; | ||||
Assess | ||||||
THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM | homo-2-mer | 1×NAG; 2×NAG; 1×CYS; | ||||
Assess | ||||||
Cleaved antitrypsin with P8-P6 Asp | homo-2-mer | |||||
Assess | ||||||
Cleaved antitrypsin with P10 Pro, and P9-P6 Asp | homo-2-mer | |||||
Assess | ||||||
A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENT… | monomer | 5×ZN; 1×BME; | ||||
Assess | ||||||
ALPHA1-ANTITRYPSIN | monomer | |||||
Assess | ||||||
UNCLEAVED ALPHA-1-ANTITRYPSIN | monomer | |||||
Assess | ||||||
Alpha-1-antitrypsin (Ala250Met) in the native conformation | monomer | |||||
Assess | ||||||
Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations | monomer | 2×GOL; 2×OXM; | ||||
Assess | ||||||
alpha 1-antitrypsin (C232S) complexed with GSK716 | monomer | 1×R7Z; 1×SO4; | ||||
Assess | ||||||
ALPHA-1 ANTITRYPSIN C232S COMPLEXED WITH CMPD3 | monomer | 2×GOL; 1×UL2; | ||||
Assess | ||||||
Alpha-1-antitrypsin (Ser36Arg/Glu78Arg/Glu266Arg) in the native conformation | monomer | |||||
Assess | ||||||
2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS | monomer | |||||
Assess | ||||||
Crystal structure of alpha-1-antitrypsin, crystal form B | monomer | 1×CL; | ||||
Assess | ||||||
Intact recombined alpha1-antitrypsin mutant PHE 51 to LEU | monomer | |||||
Assess | ||||||
Native alpha-1-antitrypsin at 1.5 Angstrom (Cys232Ser) | monomer | 1×GLY; 1×EDO; 1×DMS; | ||||
Assess | ||||||
Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations | monomer | 3×GOL; | ||||
Assess | ||||||
Alpha-1-antitrypsin Queen's (K154N) variant | monomer | 2×GLY; 1×H3B; | ||||
Assess | ||||||
ALPHA-1 ANTITRYPSIN (C232S) COMPLEXED WITH cmpd 11 | monomer | 1×UKZ; 1×GOL; | ||||
Assess | ||||||
1.92 angstrom crystal structure of A1AT:TTAI ternary complex | monomer | 2×GOL; | ||||
Assess | ||||||
Interactions causing the kinetic trap in serpin protein folding | monomer | 1×Z6W; | ||||
Assess | ||||||
Crystal Structure of Gly117Phe Alpha1-Antitrypsin | monomer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN | monomer | 1×NAG; | ||||
Assess | ||||||
1.8 Angstrom structure of intact native wild-type alpha-1-antitrypsin | monomer | |||||
Assess | ||||||
Alpha-1-antitrypsin Queen's (Lys154Asn) variant | monomer | 1×GLY; | ||||
Assess | ||||||
Alpha-1-antitrypsin - Sydney variant (G192C) | monomer | |||||
Assess | ||||||
2.2 Angstrom Crystal Structure of Thr114Phe Alpha1-Antitrypsin | monomer | |||||
Assess | ||||||
Alpha-1-antitrypsin - Sydney variant (G192C) | monomer | |||||
Assess | ||||||
Crystal structure of alpha-1-antitrypsin complexed with citrate | monomer | 1×CIT; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION | monomer | |||||
Assess | ||||||
Crystal structure of alpha-1-antitrypsin, crystal form A | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1qlp.1.A | monomer | 0.83 | 100.00 | |||
Assess |